STOCK TITAN

AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

AbCellera (Nasdaq: ABCL) will release its first-quarter 2021 financial results on May 13, 2021, and host an earnings conference call at 2:00 p.m. PT (5:00 p.m. ET). A live webcast will be accessible via the Investor Relations website, with a replay available afterward.

AbCellera specializes in antibody discovery by analyzing immune systems, partnering with various drug developers to streamline drug development processes.

Positive
  • Announcing financial results could indicate transparency and confidence in performance.
Negative
  • None.

AbCellera (Nasdaq: ABCL) will announce its first-quarter 2021 financial results on Thursday, May 13, 2021 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live webcast will be available on AbCellera’s Investor Relations website at: https://investors.abcellera.com/. Replay of the webcast will be available through the same link following the conference call.

About AbCellera

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

FAQ

When will AbCellera announce its Q1 2021 financial results?

AbCellera will announce its Q1 2021 financial results on May 13, 2021.

What time is the earnings conference call for AbCellera?

The earnings conference call will take place at 2:00 p.m. Pacific Time on May 13, 2021.

Where can I listen to the AbCellera earnings call?

The earnings call can be listened to live on AbCellera's Investor Relations website.

What does AbCellera do?

AbCellera is a technology company that discovers antibodies to develop drugs for disease prevention and treatment.

AbCellera Biologics Inc. Common Shares

NASDAQ:ABCL

ABCL Rankings

ABCL Latest News

ABCL Stock Data

815.21M
208.42M
27.99%
38.21%
5.63%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER